TOUJEO MAX SOLOSTAR FDA approval date

The FDA approved TOUJEO MAX SOLOSTAR on 25 Feb 2015.

FDA approval date
25 Feb 2015

Drug identity has not yet been verified against registry records

Also recorded as INSULIN GLARGINE RECOMBINANT

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2015-02-25DayTOUJEO MAX SOLOSTARFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA206538", "applicant_as_listed_by_fda": "SANOFI US SERVICES", "brand_names": ["TOUJEO MAX SOLOSTAR", "TOUJEO SOLOSTAR"], "active_ingredients": ["INSULIN GLARGINE RECOMBINANT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150225", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026